Position in AZN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,503,689,491
New position
Shares Held
7,624,427
first reported quarter
Ownership
0.492%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $4,969,350,861 across 12 Drug Manufacturers - General names. AZN ranks #1 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
7,624,427 | $1,503,689,491 | |
| 2 | LLY |
ELI LILLY & Co
|
1,157,476 | $1,064,611,698 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
4,423,414 | $616,491,207 | |
| 4 | JNJ |
Johnson & Johnson
|
1,642,509 | $401,494,898 | |
| 5 | ABBV |
AbbVie Inc.
|
1,491,841 | $324,460,498 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,316,095 | $278,603,066 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,407,916 | $267,340,104 | |
| 8 | AMGN |
Amgen Inc
|
741,006 | $260,722,960 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,503,689,491 | 7,624,427 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||